Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

Phase 4

2(100.0%)

2Total

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06392828Completed

EndoNAFLD: Relationship Between Fatty Liver Disease and Cardiovascular Diseases

Role: collaborator

NCT07431892Recruiting

Pain Evaluation Across Robotic and Laparoscopic Surgery for Colorectal Procedures

Role: lead

NCT06285760Recruiting

Effect of Acetazolamide on Diuresis and Natriuresis in Patients With Acute Heart Failure (SANDI STUDY)

Role: collaborator

NCT04311385Completed

Management and Evolution of Acute Diverticulitis With Pericolic Free Gas

Role: lead

NCT04194151Phase 4Completed

Impact of Propofol Reduction in Anesthesia Induction

Role: lead

NCT01733940Phase 4Unknown

Efficacy of Tegaderm-CHG® Dressing vs. Tegaderm-IV® Dressing

Role: lead

All 6 trials loaded